Wan‐Jou Shen

431 total citations
20 papers, 293 citations indexed

About

Wan‐Jou Shen is a scholar working on Molecular Biology, Infectious Diseases and Computational Theory and Mathematics. According to data from OpenAlex, Wan‐Jou Shen has authored 20 papers receiving a total of 293 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 8 papers in Infectious Diseases and 3 papers in Computational Theory and Mathematics. Recurrent topics in Wan‐Jou Shen's work include Clostridium difficile and Clostridium perfringens research (5 papers), RNA modifications and cancer (4 papers) and Viral gastroenteritis research and epidemiology (3 papers). Wan‐Jou Shen is often cited by papers focused on Clostridium difficile and Clostridium perfringens research (5 papers), RNA modifications and cancer (4 papers) and Viral gastroenteritis research and epidemiology (3 papers). Wan‐Jou Shen collaborates with scholars based in Taiwan, United States and China. Wan‐Jou Shen's co-authors include Julian G. Hurdle, Kevin W. Garey, Kelli L. Palmer, Kirk E. Hevener, Wei‐Jan Wang, Bradley T. Endres, Abiola Olumuyiwa Olaitan, Anne J Gonzales-Luna, Gangga Anuraga and Hoang Dang Khoa Ta and has published in prestigious journals such as Nature Communications, Biochemical and Biophysical Research Communications and Journal of Clinical Microbiology.

In The Last Decade

Wan‐Jou Shen

19 papers receiving 292 citations

Peers

Countries citing papers authored by Wan‐Jou Shen

Since Specialization

Citations

This map shows the geographic impact of Wan‐Jou Shen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wan‐Jou Shen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wan‐Jou Shen more than expected).

Fields of papers citing papers by Wan‐Jou Shen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wan‐Jou Shen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wan‐Jou Shen. The network helps show where Wan‐Jou Shen may publish in the future.

Co-authorship network of co-authors of Wan‐Jou Shen

This figure shows the co-authorship network connecting the top 25 collaborators of Wan‐Jou Shen. A scholar is included among the top collaborators of Wan‐Jou Shen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wan‐Jou Shen. Wan‐Jou Shen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	miR-6126 modulates GRP78 to suppress the Warburg effect and mitochondrial dynamics in triple-negative breast cancer 2025 ·International Journal of Medical Sciences ·Wei‐Jan Wang, (unknown), (unknown), Wan‐Jou Shen, Chih‐Jung Chen, Shuo Chen, (unknown), Chih‐Yang Huang, Wei-Wen Kuo	1
2	Novel SARS-CoV-2 inhibition properties of the anti-cancer Kang Guan Recipe herbal formula 2024 ·Cancer Letters ·Wei‐Jan Wang, (unknown), (unknown), Wan‐Jou Shen, Chung‐Yu Chen, (unknown), Sui‐Yuan Chang, Wei‐Chao Chang, Po‐Ren Hsueh, Sheng‐Teng Huang, Mien‐Chie Hung	0
3	Multiple Comprehensive Analyses Identify Lysine Demethylase KDM as a Potential Therapeutic Target for Pancreatic Cancer 2024 ·International Journal of Medical Sciences ·Wan‐Jou Shen, (unknown), Chih‐Yang Wang, (unknown), (unknown), Ching‐Chung Ko, Hung‐Yun Lin, Hoang Dang Khoa Ta, Gangga Anuraga, (unknown), (unknown), (unknown), (unknown), Wei‐Jan Wang	2
4	Inhibition of Galectin-9 sensitizes tumors to anthracycline treatment via inducing antitumor immunity 2023 ·International Journal of Biological Sciences ·Xian Wen Sun, Wei‐Jan Wang, (unknown), Ri‐Yao Yang, Wan‐Jou Shen, Linlin Sun, Jung-Mao Hsu, Li-Chuan Chan, Chia-Wei Li, Weiya Xia, Baozhen Ke, Guo‐Dong Yao, Ke-Bin Huang, Pei‐Chih Lee, Paul Koller, Mien‐Chie Hung	8
5	The natural tannins oligomeric proanthocyanidins and punicalagin are potent inhibitors of infection by SARS-CoV-2 2023 ·eLife ·Hsiao‐Fan Chen, Wei‐Jan Wang, Chung‐Yu Chen, Wei‐Chao Chang, Po‐Ren Hsueh, Shin‐Lei Peng, (unknown), Yeh Chen, Hsin‐Yu Huang, Wan‐Jou Shen, Shao‐Chun Wang, Mien‐Chie Hung	14
6	Decoding a cryptic mechanism of metronidazole resistance among globally disseminated fluoroquinolone-resistant Clostridioides difficile 2023 ·Nature Communications ·Abiola Olumuyiwa Olaitan, Chetna Dureja, (unknown), Madeline A. Topf, Wan‐Jou Shen, Anne J Gonzales-Luna, (unknown), Kirk E. Hevener, Jane Freeman, Mark H. Wilcox, Kelli L. Palmer, Kevin W. Garey, Caitlin S. Pepperell, Julian G. Hurdle	30
7	Novel Potential Therapeutic Targets of PTPN Families for Lung Cancer 2022 ·Journal of Personalized Medicine ·Chin‐Chou Wang, (unknown), Wan‐Jou Shen, Gangga Anuraga, Hoang Dang Khoa Ta, (unknown), (unknown), (unknown), Jiazhen Jiang, Zhengda Sun, (unknown), (unknown), Wei‐Jan Wang	6
8	Penetrating Exploration of Prognostic Correlations of the FKBP Gene Family with Lung Adenocarcinoma 2022 ·Journal of Personalized Medicine ·Chin‐Chou Wang, Wan‐Jou Shen, Gangga Anuraga, (unknown), Hoang Dang Khoa Ta, (unknown), (unknown), Chih‐Yang Wang, Wei‐Jan Wang	7
9	Peimine inhibits variants of SARS‐CoV ‐2 cell entry via blocking the interaction between viral spike protein and ACE2 2022 ·Journal of Food Biochemistry ·Wei‐Jan Wang, Yeh Chen, Wen‐Chi Su, Yen‐Yi Liu, Wan‐Jou Shen, Wei‐Chao Chang, Sheng‐Teng Huang, Cheng‐Wen Lin, (unknown), Chia‐Shin Yang, (unknown), Yu‐Chi Chou, Yang‐Chang Wu, Shao‐Chun Wang, Mien‐Chie Hung	10
10	Circadian rhythm-related factors of PER and CRY family genes function as novel therapeutic targets and prognostic biomarkers in lung adenocarcinoma 2022 ·Aging ·Chin‐Chou Wang, Wei-Hsun Lin, (unknown), Wan‐Jou Shen, Hoang Dang Khoa Ta, Gangga Anuraga, (unknown), (unknown), (unknown), (unknown), Chih‐Yang Wang, Wei‐Jan Wang	14
11	Potential Prognostic Biomarkers of OSBPL Family Genes in Patients with Pancreatic Ductal Adenocarcinoma 2021 ·Biomedicines ·(unknown), (unknown), (unknown), Wan‐Jou Shen, Gangga Anuraga, Hoang Dang Khoa Ta, Kuen‐Haur Lee, Yu‐Cheng Lee, Cheng‐Hsien Lin, Chih‐Yang Wang, Wei‐Jan Wang	19
12	Potential natural products that target the SARS-CoV-2 spike protein identified by structure-based virtual screening, isothermal titration calorimetry and lentivirus particles pseudotyped (Vpp) infection assay 2021 ·Journal of Traditional and Complementary Medicine ·Guanyu Chen, (unknown), Tung‐Ying Wu, (unknown), Wei‐Jan Wang, Wan‐Jou Shen, Azaj Ahmed, Shu-Ting Chan, Chih‐Hsin Tang, Wei‐Chien Huang, Mien‐Chie Hung, Juan‐Cheng Yang, Yang‐Chang Wu	15
13	MCL1 participates in leptin-promoted mitochondrial fusion and contributes to drug resistance in gallbladder cancer 2021 ·JCI Insight ·Wei‐Jan Wang, (unknown), Fei Zhang, Wan‐Jou Shen, Pei‐Yu Chu, (unknown), Yingbin Liu, Ju‐Ming Wang	23
14	The Integrity of Heme Is Essential for Reproducible Detection of Metronidazole-Resistant Clostridioides difficile by Agar Dilution Susceptibility Tests 2021 ·Journal of Clinical Microbiology ·Xiaoqian Wu, Wan‐Jou Shen, (unknown), Abiola Olumuyiwa Olaitan, Kelli L. Palmer, Kevin W. Garey, Julian G. Hurdle	20
15	Reduced Susceptibility to Metronidazole Is Associated With Initial Clinical Failure in Clostridioides difficile Infection 2021 ·Open Forum Infectious Diseases ·Anne J Gonzales-Luna, Abiola Olumuyiwa Olaitan, Wan‐Jou Shen, (unknown), Travis J Carlson, (unknown), (unknown), Khurshida Begum, Mohammad Jahangir Alam, Julian G. Hurdle, Kevin W. Garey	27
16	Constitutive expression of the cryptic vanGCd operon promotes vancomycin resistance in Clostridioides difficile clinical isolates 2019 ·Journal of Antimicrobial Chemotherapy ·Wan‐Jou Shen, (unknown), Kirk E. Hevener, Bradley T. Endres, Kevin W. Garey, Kelli L. Palmer, Julian G. Hurdle	50
17	710. Increased Clinical Failure Rates Associated with Reduced Metronidazole Susceptibility in Clostridioides difficile 2018 ·Open Forum Infectious Diseases ·Anne J Gonzales-Luna, Wan‐Jou Shen, (unknown), (unknown), Bradley T. Endres, (unknown), Khurshida Begum, Patricia L. Cernoch, Katherine K. Perez, (unknown), (unknown), Kenneth L. Muldrew, Mohammad Jahangir Alam, Kevin W. Garey, Julian G. Hurdle	1
18	Pharmacophore Modeling, Synthesis, and Antibacterial Evaluation of Chalcones and Derivatives 2018 ·ACS Omega ·Mingming Zhang, Allan M. Prior, Marcus M. Maddox, Wan‐Jou Shen, Kirk E. Hevener, David F. Bruhn, Robin B. Lee, Aman Preet Singh, (unknown), Charles J. Simmons, Julian G. Hurdle, Richard Lee, Dianqing Sun	23
19	A modified fixed staining method for the simultaneous measurement of reactive oxygen species and oxidative responses 2012 ·Biochemical and Biophysical Research Communications ·Wan‐Jou Shen, (unknown), Chia‐Ling Chen, (unknown), (unknown), (unknown), Chiou‐Feng Lin	12
20	Effects of Copper Coordinate Complexes on the Scavenging of Reactive Oxygen Species 1993 ·Biochemical and Biophysical Research Communications ·(unknown), Yun-Zhong Fang, Chuang Sun, Wan‐Jou Shen, (unknown), (unknown)	11

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact